Johnson & Johnson gets Emergency Use Approval for its single-dose COVID-19 vaccine in India
India has so far approved four vaccines - AstraZeneca's Covishield, Bharati Biotech's Covaxin, Russian Gamaleya Institute's Sputnik V and Moderna's vaccine.
FollowThe Government of India on Saturday sanctioned the Emergency Use Authorisation of Johnson & Johnson single-dose Covid-19 vaccine. It became the fifth vaccine against coronavirus to be approved in India.
The US pharma giant had sought approval for emergency use of its single-dose Covid-19 vaccine from DGCI on Friday.
"India expands its vaccine basket! Johnson and Johnson’s single-dose COVID-19 vaccine is given approval for Emergency Use in India. Now India has 5 EUA vaccines," tweeted Union Health Minister Mansukh Mandaviya.
The pharma company's statement said that the EUA submission is based on topline efficacy and safety data from the Phase 3 clinical trial ENSEMBLE, which demonstrated their single-shot vaccine was 85% effective in preventing severe disease across all regions studied.
The pharma company stated that it is an important milestone that paves the way to bringing the single-dose Covid-19 vaccine to the people of India, and the rest of the world, through a collaboration with Biological E. Limited.
It further stated that Biological E will be an important part of Johnson and Johnson's global supply chain network, helping to supply its Covid-19 vaccine Janssen through extensive collaborations and partnerships with governments, health authorities and organisations such as Gavi and the COVAX Facility.
India reported 38,628 new Covid-19 cases in last 24 hours, taking the total tally of Covid-19 cases to 3,18,56,757. While the active cases registered an increase for the third consecutive day, the active caseload in India is now at 4,12,153, the data showed.
As many as 49,55,138 people were vaccinated in the last 24 hours, the government has said. A total of 50,10,09,609 people have been vaccinated so far in the country.
India has so far approved four vaccines - AstraZeneca's Covishield, Bharati Biotech's Covaxin, Russian Gamaleya Institute's Sputnik V and Moderna's vaccine.
NOTE: Asianet News humbly requests everyone to wear masks, sanitize, maintain social distancing and get vaccinated as soon as eligible. Together we can and will break the chain #ANCares #IndiaFightsCorona
